BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 21402443)

  • 1. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.
    Chen J; Joshi SK; DiDomenico S; Perner RJ; Mikusa JP; Gauvin DM; Segreti JA; Han P; Zhang XF; Niforatos W; Bianchi BR; Baker SJ; Zhong C; Simler GH; McDonald HA; Schmidt RG; McGaraughty SP; Chu KL; Faltynek CR; Kort ME; Reilly RM; Kym PR
    Pain; 2011 May; 152(5):1165-1172. PubMed ID: 21402443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels.
    Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
    Pain; 2011 May; 152(5):1156-1164. PubMed ID: 21353389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitation and modulation of TRPA1, TRPV1, and TRPM8 channel-expressing sensory neurons by the pruritogen chloroquine.
    Than JY; Li L; Hasan R; Zhang X
    J Biol Chem; 2013 May; 288(18):12818-27. PubMed ID: 23508958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.
    Nassini R; Gees M; Harrison S; De Siena G; Materazzi S; Moretto N; Failli P; Preti D; Marchetti N; Cavazzini A; Mancini F; Pedretti P; Nilius B; Patacchini R; Geppetti P
    Pain; 2011 Jul; 152(7):1621-1631. PubMed ID: 21481532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis.
    Schwartz ES; La JH; Scheff NN; Davis BM; Albers KM; Gebhart GF
    J Neurosci; 2013 Mar; 33(13):5603-11. PubMed ID: 23536075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
    Sałat K; Filipek B
    J Zhejiang Univ Sci B; 2015 Mar; 16(3):167-78. PubMed ID: 25743118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.
    Tonello R; Fusi C; Materazzi S; Marone IM; De Logu F; Benemei S; Gonçalves MC; Coppi E; Castro-Junior CJ; Gomez MV; Geppetti P; Ferreira J; Nassini R
    Br J Pharmacol; 2017 Jan; 174(1):57-69. PubMed ID: 27759880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain.
    Dai Y; Wang S; Tominaga M; Yamamoto S; Fukuoka T; Higashi T; Kobayashi K; Obata K; Yamanaka H; Noguchi K
    J Clin Invest; 2007 Jul; 117(7):1979-87. PubMed ID: 17571167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of transient receptor potential ankyrin 1 by eugenol.
    Chung G; Im ST; Kim YH; Jung SJ; Rhyu MR; Oh SB
    Neuroscience; 2014 Mar; 261():153-60. PubMed ID: 24384226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism.
    Materazzi S; Fusi C; Benemei S; Pedretti P; Patacchini R; Nilius B; Prenen J; Creminon C; Geppetti P; Nassini R
    Pflugers Arch; 2012 Apr; 463(4):561-9. PubMed ID: 22258694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPA1 receptor localisation in the human peripheral nervous system and functional studies in cultured human and rat sensory neurons.
    Anand U; Otto WR; Facer P; Zebda N; Selmer I; Gunthorpe MJ; Chessell IP; Sinisi M; Birch R; Anand P
    Neurosci Lett; 2008 Jun; 438(2):221-7. PubMed ID: 18456404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pronociceptive response elicited by TRPA1 receptor activation in mice.
    Andrade EL; Luiz AP; Ferreira J; Calixto JB
    Neuroscience; 2008 Mar; 152(2):511-20. PubMed ID: 18272293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy].
    Taguchi K
    Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPA1 and cold transduction: an unresolved issue?
    Caspani O; Heppenstall PA
    J Gen Physiol; 2009 Mar; 133(3):245-9. PubMed ID: 19237589
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
    Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
    Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
    Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPA1 contributes to cold hypersensitivity.
    del Camino D; Murphy S; Heiry M; Barrett LB; Earley TJ; Cook CA; Petrus MJ; Zhao M; D'Amours M; Deering N; Brenner GJ; Costigan M; Hayward NJ; Chong JA; Fanger CM; Woolf CJ; Patapoutian A; Moran MM
    J Neurosci; 2010 Nov; 30(45):15165-74. PubMed ID: 21068322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives.
    Nassini R; Fusi C; Materazzi S; Coppi E; Tuccinardi T; Marone IM; De Logu F; Preti D; Tonello R; Chiarugi A; Patacchini R; Geppetti P; Benemei S
    Br J Pharmacol; 2015 Jul; 172(13):3397-411. PubMed ID: 25765567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function mutations in the transient receptor potential channels TRPV1 and TRPA1: how painful?
    Boukalova S; Touska F; Marsakova L; Hynkova A; Sura L; Chvojka S; Dittert I; Vlachova V
    Physiol Res; 2014; 63(Suppl 1):S205-13. PubMed ID: 24564660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
    Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
    Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.